Journal articles on the topic 'Tumor chemoresistance'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Tumor chemoresistance.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Yeldag, Gulcen, Alistair Rice, and Armando Del Río Hernández. "Chemoresistance and the Self-Maintaining Tumor Microenvironment." Cancers 10, no. 12 (November 28, 2018): 471. http://dx.doi.org/10.3390/cancers10120471.
Full textOplt, Alyssa, Elizabeth Stock, Hollie Noia, Patrick Cannon, Gregory Longmore, and Katherine C. Fuh. "Abstract 3235: The role of DDR2 in chemoresistant ovarian cancer." Cancer Research 82, no. 12_Supplement (June 15, 2022): 3235. http://dx.doi.org/10.1158/1538-7445.am2022-3235.
Full textGronlund, B., E. V. S. Høgdall, I. J. Christensen, J. S. Johansen, B. Nørgaard-Pedersen, S. A. Engelholm, and C. Høgdall. "Pre-Treatment Prediction of Chemoresistance in Second-Line Chemotherapy of Ovarian Carcinoma: Value of Serological Tumor Marker Determination (Tetranectin, YKL-40, CASA, CA 125)." International Journal of Biological Markers 21, no. 3 (July 2006): 141–48. http://dx.doi.org/10.1177/172460080602100302.
Full textWu, Qitong, Sumit Siddharth, and Dipali Sharma. "Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs." Cancers 13, no. 15 (July 23, 2021): 3697. http://dx.doi.org/10.3390/cancers13153697.
Full textBelisario, Dimas Carolina, Joanna Kopecka, Martina Pasino, Muhlis Akman, Enrico De Smaele, Massimo Donadelli, and Chiara Riganti. "Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance." Cells 9, no. 12 (December 4, 2020): 2598. http://dx.doi.org/10.3390/cells9122598.
Full textTrevino, J. G., S. R. Pillai, and S. P. Chellappan. "Effect of nicotine on chemoresistant phenotype as mediated through Src-dependent Id1 expression in pancreatic adenocarcinoma cells." Journal of Clinical Oncology 29, no. 4_suppl (February 1, 2011): 216. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.216.
Full textJi, Ping, Kristen M. Turner, and Wei Zhang. "OverAKT3: tumor progression and chemoresistance." Cell Cycle 14, no. 13 (June 4, 2015): 1993–94. http://dx.doi.org/10.1080/15384101.2015.1046787.
Full textBrown, Elizabeth, and Maurie Markman. "Tumor chemosensitivity and chemoresistance assays." Cancer 77, no. 6 (March 15, 1996): 1020–25. http://dx.doi.org/10.1002/(sici)1097-0142(19960315)77:6<1020::aid-cncr3>3.0.co;2-l.
Full textCree, Ian A., Russell D. Petty, Christian M. Kurbacher, and Michael Untch. "Tumor chemosensitivity and chemoresistance assays." Cancer 78, no. 9 (November 1, 1996): 2031–32. http://dx.doi.org/10.1002/(sici)1097-0142(19961101)78:9<2031::aid-cncr27>3.0.co;2-x.
Full textKern, David H. "Tumor chemosensitivity and chemoresistance assays." Cancer 79, no. 7 (April 1, 1997): 1447–49. http://dx.doi.org/10.1002/(sici)1097-0142(19970401)79:7<1447::aid-cncr23>3.0.co;2-z.
Full textLou, Emil, Rachel Isaksson Vogel, Spencer Hoostal, Aaron Grad, Minnu Monu, Tomasz Lukaszewski, Jaai Deshpande, et al. "Tumor stroma proportion to predict platinum chemoresistance in primary ovarian carcinomas: A prospective study." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 5581. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.5581.
Full textScholler, Nathalie, and Claire Repellin. "Role of natural killer cells in ovarian cancer chemoresistance (TUM3P.1050)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 70.7. http://dx.doi.org/10.4049/jimmunol.194.supp.70.7.
Full textLee, Catherine A. A., Pallavi Banerjee, Brian J. Wilson, Siyuan Wu, Qin Guo, Gretchen Berg, Svetlana Karpova, et al. "Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism." Journal of Biological Chemistry 295, no. 22 (April 20, 2020): 7774–88. http://dx.doi.org/10.1074/jbc.ra120.013778.
Full textChen, Xun, Shangwu Chen, and Dongsheng Yu. "Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance." Metabolites 10, no. 7 (July 16, 2020): 289. http://dx.doi.org/10.3390/metabo10070289.
Full textSouza, Leonel Cardozo de Menezes e., Anderson Faletti, Carla Pires Veríssimo, Mariana Paranhos Stelling, and Helena Lobo Borges. "p53 Signaling on Microenvironment and Its Contribution to Tissue Chemoresistance." Membranes 12, no. 2 (February 9, 2022): 202. http://dx.doi.org/10.3390/membranes12020202.
Full textKiwit, Jurgen Carl Walther, Anja Hertel, and Alexander E. Matuschek. "Reversal of chemoresistance in malignant gliomas by calcium antagonists: correlation with the expression of multidrug-resistant p-glycoprotein." Journal of Neurosurgery 81, no. 4 (October 1994): 587–94. http://dx.doi.org/10.3171/jns.1994.81.4.0587.
Full textGonzález-Ortiz, Alina, Angel Pulido-Capiz, César Y. Castañeda-Sánchez, Esmeralda Ibarra-López, Octavio Galindo-Hernández, Maritza Anahí Calderón-Fernández, Leslie Y. López-Cossio, et al. "eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model." Cells 11, no. 24 (December 15, 2022): 4069. http://dx.doi.org/10.3390/cells11244069.
Full textTondo-Steele, Katelyn, and Karen McLean. "The “Sweet Spot” of Targeting Tumor Metabolism in Ovarian Cancers." Cancers 14, no. 19 (September 27, 2022): 4696. http://dx.doi.org/10.3390/cancers14194696.
Full textMehraj, Umar, Abid Hamid Dar, Nissar A. Wani, and Manzoor A. Mir. "Tumor microenvironment promotes breast cancer chemoresistance." Cancer Chemotherapy and Pharmacology 87, no. 2 (January 9, 2021): 147–58. http://dx.doi.org/10.1007/s00280-020-04222-w.
Full textWollenzien, Hannah, Yohannes Afeworki, and Michael S. Kareta. "Abstract A005: Transcriptional profiling of tumor heterogeneity and chemoresistance in small cell lung cancer." Cancer Research 82, no. 10_Supplement (May 15, 2022): A005. http://dx.doi.org/10.1158/1538-7445.evodyn22-a005.
Full textLee, Amy H., Carolina Mejia Peña, and Michelle R. Dawson. "Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations." Cancers 14, no. 6 (March 10, 2022): 1418. http://dx.doi.org/10.3390/cancers14061418.
Full textMii, Sumiyuki, Yasunori Tome, Yukihiko Hiroshima, Fuminari Uehara, Shinji Miwa, Toshiyoshi Fujiwara, Robert M. Hoffman, and Shuya Yano. "Effect of dormant cancer cells on angiogenesis after resisting chemotherapy." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e13577-e13577. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13577.
Full textDe Milito, Angelo, and Stefano Fais. "Tumor acidity, chemoresistance and proton pump inhibitors." Future Oncology 1, no. 6 (December 2005): 779–86. http://dx.doi.org/10.2217/14796694.1.6.779.
Full textvelaei, Kobra, Nasser Samadi, Balal Barazvan, and Jafar Soleimani Rad. "Tumor microenvironment-mediated chemoresistance in breast cancer." Breast 30 (December 2016): 92–100. http://dx.doi.org/10.1016/j.breast.2016.09.002.
Full textPan, C., T. Li, M. He, R. de Vere White, D. Gandara, P. Mack, P. N. Lara, K. Turteltaub, and P. Henderson. "Design of a phase 0 microdosing trial for correlation of platinum-induced DNA damage to chemotherapy outcomes." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 2543. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.2543.
Full textMalier, Marie, Khaldoun Gharzeddine, Marie-Hélène Laverriere, Sabrina Marsili, Fabienne Thomas, Thomas Decaens, Gael Roth, and Arnaud Millet. "Hypoxia Drives Dihydropyrimidine Dehydrogenase Expression in Macrophages and Confers Chemoresistance in Colorectal Cancer." Cancer Research 81, no. 23 (October 13, 2021): 5963–76. http://dx.doi.org/10.1158/0008-5472.can-21-1572.
Full textLainetti, Patrícia de Faria, Antonio Fernando Leis-Filho, Renee Laufer-Amorim, Alexandre Battazza, and Carlos Eduardo Fonseca-Alves. "Mechanisms of Resistance to Chemotherapy in Breast Cancer and Possible Targets in Drug Delivery Systems." Pharmaceutics 12, no. 12 (December 9, 2020): 1193. http://dx.doi.org/10.3390/pharmaceutics12121193.
Full textAsare-Werehene, Meshach, Hideaki Tsuyoshi, Huilin Zhang, Reza Salehi, Chia-Yu Chang, Euridice Carmona, Clifford L. Librach, et al. "Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes." Cancers 14, no. 4 (February 18, 2022): 1039. http://dx.doi.org/10.3390/cancers14041039.
Full textJust, Christina, Juliana Knief, Pamela Lazar-Karsten, Ekaterina Petrova, Richard Hummel, Christoph Röcken, Ulrich Wellner, and Christoph Thorns. "MicroRNAs as Potential Biomarkers for Chemoresistance in Adenocarcinomas of the Esophagogastric Junction." Journal of Oncology 2019 (July 29, 2019): 1–11. http://dx.doi.org/10.1155/2019/4903152.
Full textTang, Yen-An, Yu-feng Chen, Yi Bao, Sylvia Mahara, Siti Maryam J. M. Yatim, Gokce Oguz, Puay Leng Lee, et al. "Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer." Proceedings of the National Academy of Sciences 115, no. 26 (June 11, 2018): E5990—E5999. http://dx.doi.org/10.1073/pnas.1801348115.
Full textLi, Qian, Salih Demir, Álvaro Del Río-Álvarez, Rebecca Maxwell, Alexandra Wagner, Juan Carrillo-Reixach, Carolina Armengol, et al. "Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma." Cancers 14, no. 17 (August 30, 2022): 4196. http://dx.doi.org/10.3390/cancers14174196.
Full textDi Mitri, Diletta, Alberto Toso, and Andrea Alimonti. "Tumor-infiltrating myeloid cells drive senescence evasion and chemoresistance in tumors." OncoImmunology 4, no. 9 (June 3, 2015): e988473. http://dx.doi.org/10.4161/2162402x.2014.988473.
Full textRinkenbaugh, Amanda L., Vidya C. Sinha, Pankaj Singh, Yuan Qi, Jiansu Shao, Xiaomei Zhang, Gloria V. Echeverria, W. Fraser Symmans, Stacy L. Moulder, and Helen Piwnica-Worms. "Abstract 1595: Analysis of spatiotemporal phenotypic heterogeneity in chemoresistant triple negative breast cancer using imaging mass cytometry." Cancer Research 82, no. 12_Supplement (June 15, 2022): 1595. http://dx.doi.org/10.1158/1538-7445.am2022-1595.
Full textHodge, McKaela A., Tasha Miller, Marcus A. Weinman, Brandan Wustefeld-Janssens, Shay Bracha, and Brian W. Davis. "Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line." Genes 14, no. 3 (February 23, 2023): 558. http://dx.doi.org/10.3390/genes14030558.
Full textMelcher, Viktoria, Monika Graf, Marta Interlandi, Natalia Moreno, Flavia W. de Faria, Su Na Kim, Dennis Kastrati, et al. "ATRT-14. MACROPHAGE-TUMOR CELL INTERACTION PROMOTES ATRT PROGRESSION AND CHEMORESISTANCE." Neuro-Oncology 22, Supplement_3 (December 1, 2020): iii278. http://dx.doi.org/10.1093/neuonc/noaa222.013.
Full textWang, Xu, Xin Wang, Midie Xu, and Weiqi Sheng. "Effects of CAF-Derived MicroRNA on Tumor Biology and Clinical Applications." Cancers 13, no. 13 (June 24, 2021): 3160. http://dx.doi.org/10.3390/cancers13133160.
Full textThege, Fredrik I., Ian I. Cardle, Conor N. Gruber, Megan J. Siemann, Sophie Cong, Katharina Wittmann, Justin Love, and Brian J. Kirby. "Acquired chemoresistance drives spatial heterogeneity, chemoprotection and collective migration in pancreatic tumor spheroids." PLOS ONE 17, no. 5 (May 26, 2022): e0267882. http://dx.doi.org/10.1371/journal.pone.0267882.
Full textFaruqi, Fahad Ahmed, Mohammad Jalalirad, Antonino Bonaventura D'Assoro, Tufia C. Haddad, Jodi M. Carter, Judy Caroline Boughey, Leiwei Wang, Matthew P. Goetz, and James N. Ingle. "Dual TGF-β and AURKA targeting enhances chemosensitivity in triple-negative breast cancer." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e13106-e13106. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13106.
Full textLee, Jiyeon, Ji-Hyun Hwang, Harim Chun, Wonjin Woo, Sekyung Oh, Jungmin Choi, and Lark Kyun Kim. "PLEKHA8P1 Promotes Tumor Progression and Indicates Poor Prognosis of Liver Cancer." International Journal of Molecular Sciences 22, no. 14 (July 16, 2021): 7614. http://dx.doi.org/10.3390/ijms22147614.
Full textCeccarelli, Simona, Francesca Megiorni, Diana Bellavia, Cinzia Marchese, Isabella Screpanti, and Saula Checquolo. "Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells." Stem Cells International 2019 (January 6, 2019): 1–8. http://dx.doi.org/10.1155/2019/6264931.
Full textHe, Lin, Neda Wick, Sharon Koorse Germans, and Yan Peng. "The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer." Cancers 13, no. 24 (December 9, 2021): 6209. http://dx.doi.org/10.3390/cancers13246209.
Full textOgbu, Stella C., Samuel Rojas, John Weaver, Phillip R. Musich, Jinyu Zhang, Zhi Q. Yao, and Yong Jiang. "DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells." Cells 11, no. 1 (December 29, 2021): 97. http://dx.doi.org/10.3390/cells11010097.
Full textHuang, Menggui, Duo Zhang, Janet Y. Wu, Kun Xing, Eujin Yeo, Chunsheng Li, Lin Zhang, et al. "Wnt-mediated endothelial transformation into mesenchymal stem cell–like cells induces chemoresistance in glioblastoma." Science Translational Medicine 12, no. 532 (February 26, 2020): eaay7522. http://dx.doi.org/10.1126/scitranslmed.aay7522.
Full textPalliyage, Gayathri Heenatigala, Rajib Ghosh, and Yon Rojanasakul. "Cancer chemoresistance and therapeutic strategies targeting tumor microenvironment." ScienceAsia 46, no. 6 (2020): 639. http://dx.doi.org/10.2306/scienceasia1513-1874.2020.092.
Full textGanapathy-Kanniappan, Shanmugasundaram. "Rac1 repression reverses chemoresistance by targeting tumor metabolism." Cancer Biology & Therapy 21, no. 10 (August 31, 2020): 888–90. http://dx.doi.org/10.1080/15384047.2020.1809923.
Full textTesta, U., L. Pasquini, and E. Petrucci. "In vitro assays of tumor chemosensitivity and chemoresistance." Drugs of the Future 29, no. 10 (2004): 1035. http://dx.doi.org/10.1358/dof.2004.029.10.863394.
Full textTao, Shuang, Zhengyang Bai, Yaobang Liu, Yali Gao, Jia Zhou, Yangyang Zhang, and Jinping Li. "Exosomes Derived from Tumor Cells Initiate Breast Cancer Cell Metastasis and Chemoresistance through a MALAT1-Dependent Mechanism." Journal of Oncology 2022 (June 30, 2022): 1–16. http://dx.doi.org/10.1155/2022/5483523.
Full textPeri, Sara, Alessio Biagioni, Giampaolo Versienti, Elena Andreucci, Fabio Staderini, Giuseppe Barbato, Lisa Giovannelli, et al. "Enhanced Vasculogenic Capacity Induced by 5-Fluorouracil Chemoresistance in a Gastric Cancer Cell Line." International Journal of Molecular Sciences 22, no. 14 (July 19, 2021): 7698. http://dx.doi.org/10.3390/ijms22147698.
Full textValle, Sandra, Laura Martin-Hijano, Sonia Alcalá, Marta Alonso-Nocelo, and Bruno Sainz Jr. "The Ever-Evolving Concept of the Cancer Stem Cell in Pancreatic Cancer." Cancers 10, no. 2 (January 26, 2018): 33. http://dx.doi.org/10.3390/cancers10020033.
Full textRichards, Katherine E., Weikun Xiao, and Reginald Hill. "Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes." Cancers 14, no. 11 (June 6, 2022): 2812. http://dx.doi.org/10.3390/cancers14112812.
Full text